TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
INCR

InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.10$ -2.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement INCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% – – – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
33.2% 38.5% – – – 83.4% 50.8% 58.5% 60.1% 70.4% 87.3% 87.7%
66.8% 61.6% – – – 16.6% 49.2% 41.5% 39.9% 29.6% 12.7% 12.3%
0.9% – – – – 19.2% 2.4% 0.6% 0.2% 0.1% 0.2% 0.1%
56.2% 144.3% – – – 888.0% 31.4% 20.6% 23.6% 18.1% 26.3% 22.3%
114.1% 240.8% – – – 54.8% 108.2% 28.7% 26.9% 41.2% 40.8% 9.8%
-47.3% -179.2% – – – -38.3% -59.0% 12.8% 13.0% -11.7% -28.1% 2.5%
1.9% 14.8% – – – 22.1% 0.8% 2.3% 3.8% 6.8% 8.6% 7.3%
-67.1% -134.0% – – – -73.6% -58.9% 8.5% 11.3% -17.2% -36.6% -16.3%
0.0% -55.7% – – – -7.5% -3.5% 5.2% 0.0% 0.6% -6.1% -2.7%
-67.1% -134.0% – – – -66.0% -57.2% 2.1% 11.5% -17.4% -28.4% -13.2%
-66.7% -117.1% – – – -42.2% -53.1% 14.2% 18.1% -6.7% -21.5% -2.7%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?